Revolut reported that the incident affected a limited number of customers / Photo: Ascannio / Shutterstock.com
News·
Data from some Revolut customers was leaked
Ad campaigns featuring movie and sports stars have boosted American Eagles brand recognition / Photo: Zoltan Tarlacz / Shutterstock.com
Small Caps·
Small caps last week: Chewy's earnings miss, Signet's best day ever, AE rethinks ads
Following the chipmaker boom, capital is shifting toward other bottlenecks in AI infrastructure: energy, data centers, and cloud computing. Photo: Shutterstock.com
Review·
The iPhone Reboot, the AGI Era, and Silicon Valley's Right Turn
As part of a test, the company tasked AI agents with filling out spreadsheets and creating reports, but instead, they went and spammed RubyGems / Photo: Tada Images / Shutterstock
News·
Spam from OpenAI's AI agents disrupted the developer service for four days
News·
Citrini, the founder who spooked the market with his prediction of AI threats, has sold the company. What's next?
News·
Dell's stock reached an all-time high. Dell has joined the ranks of the world's top three richest people
News·
The "AI-Nostradamus" Fund has changed its approach to risk and stepped up its buying. Where is it investing?
News·
Inflation Didn't Scare Investors: U.S. Indices Gained Nearly 1% After Four Days of Losses
Stock Screener
Buy
Sell
Go to section
Guru Portfolios

Track the investments of top funds and market legends

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Go to section
Small Caps
Chewy shares slid after unremarkable quarterly earnings, while the management raised its fiscal-year net sales guidance / Photo: Facebook/Chewy
Small Caps·
Pet supplies retailer Chewy has worst day in a year amid 'unremarkable' results
Small Caps·
American Eagle to move away from big ad campaigns amid sluggish sales
Small Caps·
What explains the outperformance of smaller bitcoin miners versus the cryptocurrency?
Small Caps·
Signet Jewelers on track for largest one-day gain in over a year on strong earnings
Small Caps·
Mid-cap biotech Dyne becomes collateral damage of another Novartis pipeline setback
Go to section

Investment and Finance News